UBC Innovation Is Advanced By The Centre For Drug Research And Development And Licensed By Global Healthcare Company
The University of British Columbia (UBC) and the Centre for Drug Research and Development (CDRD) recently announced that Covidien, a leading global provider of healthcare products, has licensed an innovative drug-delivery platform technology invented by UBC researcher, Pieter Cullis
World Leading Product Development Company Sagentia Announces Expansion of US Operations Through New Cambridge Office
Sagentia, an international technology and product development company based in Cambridge, U.K., and the Massachusetts Life Sciences Center announced today the recent opening of Sagentia’s new Cambridge, Massachusetts location.
Personalized Medicines Are Shaping the Way R&D Is Done, According to Tufts Center for the Study of Drug Development
BOSTON, MA–(Marketwire – 11/16/10) – Personalized medicine development, occupying a growing role in the clinical pipelines of drug developers, is leading companies to change their R&D paradigms, including how they make go/no-go decisions, according to a recently completed study by the Tufts Center for the Study of Drug Development. “Early indications show that development of personalized …
Kineta Wins New NIH Contract Aimed at Speeding Development of Novel Drug Classes
SEATTLE–(BUSINESS WIRE)–Kineta announced today the award of its second NIH contract in twelve months. It is focused on mining vast, existing, basic research with the goal of identifying new drug targets and drug candidates.
UC Berkeley Extension offers new options for career development in biotechnology
Biotechnology professionals in the Bay Area have three new options for career development from UC Berkeley Extension. The professional programs in Regulatory Affairs, Biopharmaceutical Product and Process Development, and Bioscience Manufacturing and Supply Chain join the education leader’s lineup of programs and certificates designed to meet the biotechnology industry’s demand for trained …
David Beyerlein, VP of Global Operations at MicroConstants, Inc., discusses how MicroConstants’ scientific knowledge and use of the most innovative Waters UPLC/MS systems allows the Contract Research Organization (CRO) to solve their clients’ problems and provide the drug development industry with the highest quality contract research services. MicroConstants is a GLP-compliant Contract Research Organization (CRO) in San Diego, California that is dedicated to providing premier quality GLP bioanalytical services, IND-enabling drug metabolism (DMPK) assays, immunoassay and biomarker analysis, and pharmacokinetics analysis services to pharmaceutical and biotech companies worldwide.
David Johnson, the Director of DMPK at MicroConstants, Inc., discusses how MicroConstants’ scientific knowledge and use of the most innovative Waters UPLC/MS systems allows the Contract Research Organization (CRO) to solve their clients’ problems and provide the drug development industry with the highest quality contract research services. MicroConstants is a GLP-compliant Contract Research Organization (CRO) in San Diego, California that is dedicated to providing premier quality GLP bioanalytical services, IND-enabling drug metabolism (DMPK) assays, immunoassay and biomarker analysis, and pharmacokinetics analysis services to pharmaceutical and biotech companies worldwide.
The Centre for Drug Research and Development Appoints John Babcook as Vice President of new Biologics Division
VANCOUVER, BC–(BUSINESS WIRE)–The Centre for Drug Research and Development (CDRD) today announced that John Babcook will head up a new biologics division at CDRD.
